Khaled Mohamed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Khaled Mohamed has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Hoda Samir El-Sayed
Dairy Science Department, Food Industries and Nutrition Institute, National Research Centre, Dokki, Cairo 12622, Egypt
1 shared publication - Maha A. Hilal
Forensic Medicine & Clinical Toxicology Department, Faculty of Medicine, Sohag University, Sohag, Egypt
1 shared publication - Mosab M. Rashwan
Forensic Medicine & Clinical Toxicology Department, Faculty of Medicine, Sohag University, Sohag, Egypt
1 shared publication Walaa Allam
Forensic Medicine & Clinical Toxicology Department, Faculty of Medicine, Sohag University, Sohag, Egypt
1 shared publication
Latest Publications
- Open Access
- 1 July 2022
- Published by Egyptian Knowledge Bank in Ain Shams Journal of Forensic Medicine and Clinical Toxicology
- Vol. 39 (2) , 72-76
Review on AMB-FUBINACA one of synthetic cannabinoids present in Egypt
Background: Synthetic cannabinoids are currently the largest group of new psychoactive substances. Those that have been subjected to legal control are replaced by newer uncontrolled substances, which cause constant and dynamic changes to the drug market. AMB-FUBINACA is one of the recent synthetic cannabinoids appeared globally. In 2018, the official spokesman for the Ministry of Health in Egypt announced that the Strox consists of five types of synthetic cannabinoids which have been added to the Egyptian list of highly addictive and dangerous narcotics. These SCs are; AB-FUBINACA, AMB-FUBINACA, 5F-ADB, AB-CHMINACA, and XLR-11. Aim of the work: To spotlight the toxic effect of AMB-FUBINACA as a new synthetic cannabinoid. Conclusion: AMB-FUBINACA has been the focus of interest by health care professionals, as their use put the health of many humans at risk especially young adults. Received in original form: 24 December 2021 Accepted in a final form: 30 June 2022
- 1 July 2022
- Published by Egyptian Knowledge Bank in Ain Shams Journal of Forensic Medicine and Clinical Toxicology
- Vol. 39 (2) , 72-76
Open AccessReview on AMB-FUBINACA one of synthetic cannabinoids present in Egypt
Background: Synthetic cannabinoids are currently the largest group of new psychoactive substances. Those that have been subjected to legal control are replaced by newer uncontrolled substances, which cause constant and dynamic changes to the drug market. AMB-FUBINACA is one of the recent synthetic cannabinoids appeared globally. In 2018, the official spokesman for the Ministry of Health in Egypt announced that the Strox consists of five types of synthetic cannabinoids which have been added to the Egyptian list of highly addictive and dangerous narcotics. These SCs are; AB-FUBINACA, AMB-FUBINACA, 5F-ADB, AB-CHMINACA, and XLR-11. Aim of the work: To spotlight the toxic effect of AMB-FUBINACA as a new synthetic cannabinoid. Conclusion: AMB-FUBINACA has been the focus of interest by health care professionals, as their use put the health of many humans at risk especially young adults. Received in original form: 24 December 2021 Accepted in a final form: 30 June 2022